Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
about
Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5An update on the genetics of pheochromocytomaMolecular markers of paragangliomas/pheochromocytomasParagangliomas/Pheochromocytomas: clinically oriented genetic testingSystematic genetic screening in a prospective group of Danish patients with pheochromocytoma.MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.Current approaches and recent developments in the management of head and neck paragangliomas.Metastatic paraganglioma.Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.Genetic testing for pheochromocytoma.Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.A rare case of juvenile hypertension: coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism.Paraganglioma Presenting as Postpartum Fever of Unknown Origin.Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.Subclinical phaeochromocytoma.False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad.Clinical Next Generation Sequencing for Precision Medicine in Cancer.Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomasRole of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.The approach to the patient with paraganglioma.Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.Familial pheochromocytomas and paragangliomas.Neuroendocrine tumors and tumor syndromes in childhood.18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomasRecent advances in the genetics of SDH-related paraganglioma and pheochromocytomaMalignant pheochromocytomas and paragangliomas: a diagnostic challenge.Screening for pheochromocytomas and paragangliomas.Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.Hereditary pheochromocytoma and paraganglioma.Cancer genomics and inherited risk.Genetic status determines (18) F-FDG uptake in pheochromocytoma/paraganglioma.Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.
P2860
Q26782841-F84FD856-7D93-4790-908A-4D119837B7F4Q26798384-845F50A5-D76F-46EA-82A1-2A68A613E020Q27024087-BE120FD5-278D-48B4-9973-335616249740Q33649025-9688B597-2B48-4A41-B95E-E90ACEDBA79BQ33679204-9B9EAF15-558D-4A07-AA55-7FD257718BEAQ33878831-8F755308-3EF6-43FA-9F01-4B1F4306030EQ34136208-E935591A-188F-414E-ADD8-DE310C633F2AQ34204524-043129F1-0D70-49C2-A295-31EC037AEC56Q34480015-7C5D9592-07A5-4392-A28D-D8BE77E718C2Q34622491-8D1E5896-E058-4459-B627-9E922F48A5C3Q34700634-F58B1018-8F8B-4EF6-97BB-DA119889E065Q34921220-6FB1C997-F829-433F-94BE-AB63BBB2BDBFQ35190348-F1EA02F7-1DEB-4A42-B715-55C75F66EEE5Q35666683-E319A4B0-A479-49BE-AA4A-7A9BFE20B27DQ35868768-C1220C1F-BF05-4E8E-8288-C863C157E88AQ35947217-82CCC9BB-6F7C-4B39-BEF0-DCD64A9ECC2FQ36125143-4FEF5A21-95E4-44B8-8EC2-22FBA5AC2B3EQ36145100-C10E9B00-0DE5-4617-BA22-E0E62C98A036Q36167038-DFBBD15F-2607-41DF-8E8C-389B57B4E85DQ36467134-B8C3FB7A-C2F9-49A9-AC48-127D835627FAQ36489471-BDDD4897-00D7-458B-9F49-203BC1AE5E7BQ36613044-02514AB6-6CE0-4A55-B67E-14F365BC28F1Q36730594-29ED200E-450E-4FC7-8B18-FFC4D0E6C924Q37202015-A50FA3BB-6348-4CDA-BBEC-A538D4FED19EQ37213634-AD37BDB3-CAFD-432D-A5E0-D32DBF1E6E40Q37315681-CB76FA12-19D5-46C3-9656-FFC99761A334Q37464073-E75B7F5F-3C37-4493-8058-DAFF8CB52E04Q37505830-8FFA3AC6-A4FA-41B8-989C-248B06D0943EQ37568369-3DDAEC56-92C6-45E3-AF47-41A1EDF4FAF0Q37587164-B72B7DBE-91B2-4D2A-8131-D90C95823C6AQ37640218-EE151526-FDDA-4DFE-80B2-16C5C329AEC9Q37809993-521B25D1-6F86-4111-89C4-F3894D014054Q37962361-D99E99E6-5C6B-4F76-B995-87C75B7C8202Q37976969-424DC58F-8524-49CF-ABB6-716F904650FFQ37994888-21966C4C-6ECC-474D-AE39-9AD0DDCC2E99Q38014788-1964622E-7A06-4D0D-B76A-4B55AF5AD953Q38180646-313A979C-3D5F-4607-9A1D-73F781A721F3Q38741404-4980F3E5-6100-466E-814C-E7EE2F10492AQ38825400-F4327EDD-F16A-4F8D-9A06-225BC6E2EA5AQ38831451-4FB48861-8A96-4FBC-9780-16DD4349503D
P2860
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@ast
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@en
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@nl
type
label
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@ast
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@en
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@nl
prefLabel
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@ast
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@en
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@nl
P2093
P50
P921
P356
P1476
Clinically guided genetic scre ...... nonfunctional paragangliomas.
@en
P2093
Alessandra Bacca
Bernadette Biondi
Erika Grossrubatscher
Franco Veglio
Gianpaolo Bernini
Giorgio Arnaldi
Giuseppe Di Trapani
Italian Pheochromocytoma/Paraganglioma Network
Luigi Mori
Mara Giacchè
P304
P356
10.1210/JC.2008-2419
P407
P50
P577
2009-02-17T00:00:00Z